![614TiPDOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, RANDOMIZED, PHASE II STUDY OF NIMOTUZUMAB IN COMBINATION WITH MITOMYCIN, 5-FLUOROURACIL AND RADIATION IN IMMUNOCOMPETENT PATIENTS WITH ANAL CARCINOMA]()
614TiPDOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, RANDOMIZED, PHASE II STUDY OF NIMOTUZUMAB IN COMBINATION WITH MITOMYCIN, 5-FLUOROURACIL AND RADIATION IN IMMUNOCOMPETENT PATIENTS WITH ANAL CARCINOMAGonzález, U. Pérez; Llano, F.F. Llorente; Suzarte, M. Ramos; Reigosa, J.E. Rodríguez; Fernández, B.F. Mestre; Rodríguez, M. Osorio; Medina, E.A. Gracia; Alvarado, M.R. Orellana; Feliú, I. Leonard; Abizaid, Y.T. Ojeda; Silva, J. Alert; Balmaseda, A.M. Ulloa; Barallobre, N.Y. González; Barrios, E. Galá; Sevillano, N. Curbelo; García, R.B. Jiménez; Flores, B.B. Brunet; Arias, M. Cedeño; Santana, R. Blanco · Annals of Oncology · 2014